A Comprehensive Review of Relacorilant in the Treatment of Platinum-Resistant Ovarian Cancer
Abstract Treating ovarian cancer that has relapsed and developed resistance or lack of response to platinum-based agents is one of the most formidable obstacles in gynecologic oncology, as clinical outcomes remain dismal despite medical advancements. Emerging research indicates that the body's natural corticosteroids c...